# OnCo record paper-shen-j-clin-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-shen-j-clin-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-shen-j-clin-oncol" ;
  schema:name "Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 35442766 and published in Journal of Clinical Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-shen-j-clin-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.21.01926>, <https://pubmed.ncbi.nlm.nih.gov/35442766/>, <https://europepmc.org/article/MED/35442766> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.21.01926> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Shen L, Kato K, Kim SB, et al." ;
  onco:trials <https://onco.cc/trials/rationale-302/> ;
  onco:journals <https://onco.cc/journals/jco/> .